Cirrhosis/Liver Failure News

Researchers have identified a unique GI bleeding syndrome associated with cirrhosis and portal hypertension, which they call “acute on chronic GI bleeding.”

AMSTERDAM — Assessment of liver stiffness and controlled attenuation parameter may be useful as a novel predictor of decompensation, according to data presented at the International Liver Congress.

AMSTERDAM — Patients with cirrhosis who were treated with human albumin experienced improvement in a number of outcomes, including overall survival, compared to standard therapy, according to data presented at the International Liver Congress.

AMSTERDAM — Approximately one-third of children under 18 years in the United Kingdom with hepatitis C developed serious long-term liver disease, according to data presented at the International Liver Congress.

AMSTERDAM — Baseline enhanced liver fibrosis score and change from that baseline independently predicted progression of nonalcoholic steatohepatitis in those with advanced fibrosis, according to a prospective study presented at the International Liver Congress.

AMSTERDAM — A cohort of 10 men with hepatic encephalopathy experienced improvement in several outcomes, including cognitive function, after fecal microbiota transplantation from the same donor, according to data presented at the International Liver Congress.

Researchers found 2D shear wave elastography had good to excellent efficiency for evaluating liver fibrosis in patients, particularly those with hepatitis B, according to a recently published study.

The FDA authorized marketing of 23andMe Personal Genome Service Genetic Health Risk tests for 10 diseases and conditions, including Alzheimer’s disease, Parkinson’s disease and celiac disease.

By defining the onset of systemic inflammation response system after acute-on-chronic liver failure, researchers suggest they can set earlier interventions and prevent early sepsis and organ failure, improving overall outcomes.

Spleen size and the mean transit time of platelets through the spleen can be used as a non-invasive method to help assess liver fibrosis, according to a recently published study.